Population screening for smoldering multiple myeloma reveals high prevalence
Smoldering multiple myeloma is an asymptomatic precursor condition to multiple myeloma, a cancer in the bone marrow. We conducted a population-based screening study — in which 51% of the population over 40 years of age in Iceland participated — and found that the prevalence of smoldering multiple my...
Gespeichert in:
Veröffentlicht in: | Nature medicine 2023-02, Vol.29 (2), p.313-314 |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 314 |
---|---|
container_issue | 2 |
container_start_page | 313 |
container_title | Nature medicine |
container_volume | 29 |
description | Smoldering multiple myeloma is an asymptomatic precursor condition to multiple myeloma, a cancer in the bone marrow. We conducted a population-based screening study — in which 51% of the population over 40 years of age in Iceland participated — and found that the prevalence of smoldering multiple myeloma was 0.5% in the study population. |
doi_str_mv | 10.1038/s41591-022-02187-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2774895082</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2778137818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c305t-b18aad22707dae4b0f7c925256792ab0f4d92d068d3bc9f070ecc2f1d07109433</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMoznh5ARdScOOmepI2TboU8QYDulBwFzLp6UyHtKnJVJi3N3W8gAsXh-SEL_9JPkJOKFxQyORlyCkvaQqMxaJSpGyHTCnPi5QKeN2NexAylSUvJuQghBUAZMDLfTLJCsE5LfiUzJ5cP1i9blyXBOMRu6ZbJLXzSWidrdCPbTvYddNbTNoNWtfqxOM7ahuSZbNYJn3stMXO4BHZq-MxHn-th-Tl9ub5-j6dPd49XF_NUhPnr9M5lVpXjAkQlcZ8DrUwJeOMF6JkOrZ5VbIKClllc1PWIACNYTWtQFAo8yw7JOfb3N67twHDWrVNMGit7tANQTEh8vhtkCyiZ3_QlRt8F183UpJmsWSk2JYy3oXgsVa9b1rtN4qCGl2rrWsVXatP12qMPv2KHuYtVj9XvuVGINsCoR81ov-d_U_sBzB2id8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2778137818</pqid></control><display><type>article</type><title>Population screening for smoldering multiple myeloma reveals high prevalence</title><source>MEDLINE</source><source>Nature</source><source>SpringerLink Journals - AutoHoldings</source><description>Smoldering multiple myeloma is an asymptomatic precursor condition to multiple myeloma, a cancer in the bone marrow. We conducted a population-based screening study — in which 51% of the population over 40 years of age in Iceland participated — and found that the prevalence of smoldering multiple myeloma was 0.5% in the study population.</description><identifier>ISSN: 1078-8956</identifier><identifier>EISSN: 1546-170X</identifier><identifier>DOI: 10.1038/s41591-022-02187-2</identifier><identifier>PMID: 36755165</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>692/308/174 ; 692/699/1541/1990/804 ; Age ; Asymptomatic ; Biomedical and Life Sciences ; Biomedicine ; Blood cancer ; Bone cancer ; Bone marrow ; Cancer Research ; Disease Progression ; Humans ; Infectious Diseases ; Medicine ; Metabolic Diseases ; Molecular Medicine ; Multiple Myeloma ; Neurosciences ; Population ; Population studies ; Prevalence ; Quality of life ; Research Briefing ; Risk Factors ; Screening ; Smoldering ; Smoldering Multiple Myeloma</subject><ispartof>Nature medicine, 2023-02, Vol.29 (2), p.313-314</ispartof><rights>Springer Nature America, Inc. 2023</rights><rights>Springer Nature America, Inc. 2023.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c305t-b18aad22707dae4b0f7c925256792ab0f4d92d068d3bc9f070ecc2f1d07109433</citedby><cites>FETCH-LOGICAL-c305t-b18aad22707dae4b0f7c925256792ab0f4d92d068d3bc9f070ecc2f1d07109433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41591-022-02187-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41591-022-02187-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36755165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><title>Population screening for smoldering multiple myeloma reveals high prevalence</title><title>Nature medicine</title><addtitle>Nat Med</addtitle><addtitle>Nat Med</addtitle><description>Smoldering multiple myeloma is an asymptomatic precursor condition to multiple myeloma, a cancer in the bone marrow. We conducted a population-based screening study — in which 51% of the population over 40 years of age in Iceland participated — and found that the prevalence of smoldering multiple myeloma was 0.5% in the study population.</description><subject>692/308/174</subject><subject>692/699/1541/1990/804</subject><subject>Age</subject><subject>Asymptomatic</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Blood cancer</subject><subject>Bone cancer</subject><subject>Bone marrow</subject><subject>Cancer Research</subject><subject>Disease Progression</subject><subject>Humans</subject><subject>Infectious Diseases</subject><subject>Medicine</subject><subject>Metabolic Diseases</subject><subject>Molecular Medicine</subject><subject>Multiple Myeloma</subject><subject>Neurosciences</subject><subject>Population</subject><subject>Population studies</subject><subject>Prevalence</subject><subject>Quality of life</subject><subject>Research Briefing</subject><subject>Risk Factors</subject><subject>Screening</subject><subject>Smoldering</subject><subject>Smoldering Multiple Myeloma</subject><issn>1078-8956</issn><issn>1546-170X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kMtKxDAUhoMoznh5ARdScOOmepI2TboU8QYDulBwFzLp6UyHtKnJVJi3N3W8gAsXh-SEL_9JPkJOKFxQyORlyCkvaQqMxaJSpGyHTCnPi5QKeN2NexAylSUvJuQghBUAZMDLfTLJCsE5LfiUzJ5cP1i9blyXBOMRu6ZbJLXzSWidrdCPbTvYddNbTNoNWtfqxOM7ahuSZbNYJn3stMXO4BHZq-MxHn-th-Tl9ub5-j6dPd49XF_NUhPnr9M5lVpXjAkQlcZ8DrUwJeOMF6JkOrZ5VbIKClllc1PWIACNYTWtQFAo8yw7JOfb3N67twHDWrVNMGit7tANQTEh8vhtkCyiZ3_QlRt8F183UpJmsWSk2JYy3oXgsVa9b1rtN4qCGl2rrWsVXatP12qMPv2KHuYtVj9XvuVGINsCoR81ov-d_U_sBzB2id8</recordid><startdate>20230201</startdate><enddate>20230201</enddate><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20230201</creationdate><title>Population screening for smoldering multiple myeloma reveals high prevalence</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c305t-b18aad22707dae4b0f7c925256792ab0f4d92d068d3bc9f070ecc2f1d07109433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>692/308/174</topic><topic>692/699/1541/1990/804</topic><topic>Age</topic><topic>Asymptomatic</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Blood cancer</topic><topic>Bone cancer</topic><topic>Bone marrow</topic><topic>Cancer Research</topic><topic>Disease Progression</topic><topic>Humans</topic><topic>Infectious Diseases</topic><topic>Medicine</topic><topic>Metabolic Diseases</topic><topic>Molecular Medicine</topic><topic>Multiple Myeloma</topic><topic>Neurosciences</topic><topic>Population</topic><topic>Population studies</topic><topic>Prevalence</topic><topic>Quality of life</topic><topic>Research Briefing</topic><topic>Risk Factors</topic><topic>Screening</topic><topic>Smoldering</topic><topic>Smoldering Multiple Myeloma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Population screening for smoldering multiple myeloma reveals high prevalence</atitle><jtitle>Nature medicine</jtitle><stitle>Nat Med</stitle><addtitle>Nat Med</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>29</volume><issue>2</issue><spage>313</spage><epage>314</epage><pages>313-314</pages><issn>1078-8956</issn><eissn>1546-170X</eissn><abstract>Smoldering multiple myeloma is an asymptomatic precursor condition to multiple myeloma, a cancer in the bone marrow. We conducted a population-based screening study — in which 51% of the population over 40 years of age in Iceland participated — and found that the prevalence of smoldering multiple myeloma was 0.5% in the study population.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>36755165</pmid><doi>10.1038/s41591-022-02187-2</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-8956 |
ispartof | Nature medicine, 2023-02, Vol.29 (2), p.313-314 |
issn | 1078-8956 1546-170X |
language | eng |
recordid | cdi_proquest_miscellaneous_2774895082 |
source | MEDLINE; Nature; SpringerLink Journals - AutoHoldings |
subjects | 692/308/174 692/699/1541/1990/804 Age Asymptomatic Biomedical and Life Sciences Biomedicine Blood cancer Bone cancer Bone marrow Cancer Research Disease Progression Humans Infectious Diseases Medicine Metabolic Diseases Molecular Medicine Multiple Myeloma Neurosciences Population Population studies Prevalence Quality of life Research Briefing Risk Factors Screening Smoldering Smoldering Multiple Myeloma |
title | Population screening for smoldering multiple myeloma reveals high prevalence |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A46%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Population%20screening%20for%20smoldering%20multiple%20myeloma%20reveals%20high%20prevalence&rft.jtitle=Nature%20medicine&rft.date=2023-02-01&rft.volume=29&rft.issue=2&rft.spage=313&rft.epage=314&rft.pages=313-314&rft.issn=1078-8956&rft.eissn=1546-170X&rft_id=info:doi/10.1038/s41591-022-02187-2&rft_dat=%3Cproquest_cross%3E2778137818%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2778137818&rft_id=info:pmid/36755165&rfr_iscdi=true |